A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2004
11/04/2004	US20040220202 antiinflammatory agents; central nervous system disorders; controlling cell proliferation, cell differentiation; anticancer agents; antidepressants
11/04/2004	US20040220188 Alkylidene pyrazolidinedione derivatives
11/04/2004	US20040220185 antiinflammatory agents; antiarthritic agents; anticancer agents
11/04/2004	US20040220183 inhibiting tumor necrosis factor; respiratory system disorders; prevent neutrophil infiltration in lungs; skin disorders
11/04/2004	US20040220175 (Pyrido/thieno) - [f] - oxazepine-5-one derivatives
11/04/2004	US20040220171 anticoagulants; immunomoderators; antiinflammatory agents
11/04/2004	US20040220163 Contraceptive method and composition
11/04/2004	US20040220149 Nerve cell survival promoters containing cyclic phosphatidic acid derivative
11/04/2004	US20040220148 5-Membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
11/04/2004	US20040220147 Antiarrhythmia agents; liver disorders; skin disorders
11/04/2004	US20040220133 Composition and method for inhibiting platelet aggregation
11/04/2004	US20040220096 Method and compositions for treating dopaminergic and gabanergic disorders
11/04/2004	US20040220092 G-protein coupled receptors
11/04/2004	US20040220079 Inhibitors of Memapsin 2 and use thereof
11/04/2004	US20040220055 Benzamidoacetonitriles and their use as antiparastics
11/04/2004	US20040219644 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents
11/04/2004	US20040219238 Prophylactic agent for enhancement of nerve growth factor production for treatment or prevention comprising an aqueous mushroom extract (xanthohumol or salts) ; neurodegenerative diseases, Alzheimer*s disease, and nervoxanthohumol andus system disorders; foods, beverages, feeds;
11/04/2004	US20040219212 Single-daily dose antidiabetic oral pharmaceutical form comprising a biguanide and at least another active principle
11/04/2004	US20040219208 Sustained-release medicines
11/04/2004	US20040219207 Drug preparation comprising alpha-lipoic acid, ambroxol and/or inhibitors of the angiotensin-converting enzyme (ACE) and its use for the treatment of neurodegenerative diseases
11/04/2004	US20040219202 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety
11/04/2004	US20040219201 Tempamine compositions and methods of use
11/04/2004	US20040219181 Sustained release drug delivery devices with coated drug cores
11/04/2004	US20040219176 dosage form of a mixture of drugs, foaming agents and gases, having improved pharmacokinetics; drug delivery systems
11/04/2004	US20040219151 Tetraspan protein and uses thereof
11/04/2004	US20040219134 implantation or attachment of an engineered three-dimensional stromal tissue to promote endothelialization and angiogenesis in the heart and related tissues
11/04/2004	US20040219123 recrystallization-resistant; also comprising a glycolic or hydroglycolic dispersed hydrophilic phase, a lipophilic continuous phase and an emulsifier having an HLB ranging from 2 to 7; preventing/treating the chronological or actinic skin aging and atrophy of the skin or mucous membranes
11/04/2004	CA2522793A1 Novel substance having .alpha.-glucosidase inhibiting activity and food containing the same
11/04/2004	CA2522562A1 2-phenyl-benzimidazol and 2-phenyl-imidazo-`4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer
11/04/2004	CA2522364A1 Polymer-conjugated glycosylated neublastin
11/03/2004	EP1473365A1 Angiogenesis inhibitors
11/03/2004	EP1473305A1 Novel glutamate receptor and utilization thereof
11/03/2004	EP1473302A1 HETEROCYCLIC COMPOUNDS HAVING ELASTASE−INHIBITING ACTIVITY AND INTERMEDIATES THEREOF
11/03/2004	EP1473295A1 Fused bicyclic pyrimidine derivatives
11/03/2004	EP1473289A1 Preventives or remedies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds
11/03/2004	EP1473038A1 Method of protecting living body from foreign factor and composition therefor
11/03/2004	EP1473036A1 Zolpidem hemitartrate solvate
11/03/2004	EP1472544A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
11/03/2004	EP1472543A2 Methods and compositions involving the hsp 90 activator aha1
11/03/2004	EP1472540A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
11/03/2004	EP1472376A2 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo
11/03/2004	EP1472364A2 Truncated aggrecanase molecules
11/03/2004	EP1472279A1 A method for inhibiting "melanoma inhibitory activity" mia
11/03/2004	EP1472278A2 Macrocyclic peptides active against the hepatitis c virus
11/03/2004	EP1472269A1 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/03/2004	EP1472267A2 Rna interference mediated inhibition of protein tyrosine phosphatase type iva (prl3) gene expression using short interfering nucleic acid (sina)
11/03/2004	EP1472257A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
11/03/2004	EP1472256A1 Piperidine derivatives
11/03/2004	EP1472255A1 Aza-arylpiperazines
11/03/2004	EP1472252A1 Substituted fused pyrazolecarboxylic acid arylamides and related compounds
11/03/2004	EP1472251A1 Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
11/03/2004	EP1472249A1 Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments
11/03/2004	EP1472244A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
11/03/2004	EP1472243A1 Piperidine derivatives and their use as antagonists of tachykinins
11/03/2004	EP1472242A1 Zoniporide mesylate pharmaceutical compositions and processes for improving solubility of zoniporide
11/03/2004	EP1472241A1 Cytoprotective benzofuran derivatives
11/03/2004	EP1472237A1 Catechol bioisosteres
11/03/2004	EP1472233A1 Pyrimidine compounds
11/03/2004	EP1472228A1 Process for the manufacture of hmg-coa reductase inhibitors
11/03/2004	EP1472225A2 2-piperazine-pyridines useful for treating pain
11/03/2004	EP1472223A1 Gamma secretase inhibitors
11/03/2004	EP1472222A1 Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
11/03/2004	EP1472220A1 Crystalline (r-(r,r))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1h-pyrrole-heptanoic acid calcium salt (2:1)
11/03/2004	EP1472216A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
11/03/2004	EP1472215A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
11/03/2004	EP1472214A2 Compounds for inhibiting insulin secretion and methods related thereto
11/03/2004	EP1471974A1 Tumor necrosis factor combined with interferon in demyelinating diseases
11/03/2004	EP1471970A2 NOVEL MAMMALIAN MULTIPOTENT STEM CELLS AND COMPOSITIONS, METHODS OF PREPARATION AND METHODS OF ADMINISTRATION THEREOF
11/03/2004	EP1471944A2 Pharmaceutical composition which improves in vivo gene transfer
11/03/2004	EP1471919A1 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist
11/03/2004	EP1471918A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
11/03/2004	EP1471917A1 Use of pde5 inhibitors such as sildenafil in the treatment of polycystic ovary syndrome
11/03/2004	EP1471915A2 2,4-pyrimidinediamine compounds and their uses
11/03/2004	EP1471913A2 Treatment of sleep disorders using sleep target modulators
11/03/2004	EP1471912A1 Method of promoting neuronal growth
11/03/2004	EP1471910A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
11/03/2004	EP1471909A1 Pharmaceutical composition and method for treating disorders of the central nervous system
11/03/2004	EP1471907A2 Use of tyrosine kinase inhibitors for treating autoimmune diseases
11/03/2004	EP1471906A1 Stimulation of cpt-1 as a means to reduce weight
11/03/2004	EP1471905A1 Use of cholinesterase antagonists to treat insulin resistance
11/03/2004	EP1471899A1 Use of ambroxol in the treatment of chronic pains, cerebral excitotoxicity-related disorders and cardiac arrhythmias
11/03/2004	EP1471892A2 Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
11/03/2004	EP1471872A2 Treatment of colds and cough with a combination of a cyclooxygenase-2 selective inhibitor and a colds and cough active ingredient and compositions thereof
11/03/2004	EP1471871A2 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin
11/03/2004	EP1471870A2 Use of lipid conjugates in the treatment of disease
11/03/2004	EP1471849A2 Post-conditioning for the reduction of ischemic-reperfusion injury in the heart and other organs
11/03/2004	EP1404315B1 Synergistic compositions of n-acylhomoserine lactones and 4-quinolones
11/03/2004	EP1377550B1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/03/2004	EP1347974B1 Aminotriazolopyridiine derivatives as adenosine receptor ligands
11/03/2004	EP1339716B1 lactam-substituted pyrazolopyridine derivatives
11/03/2004	EP1317425B1 Resorcinol derivatives
11/03/2004	EP1313732B1 Oxindole derivatives
11/03/2004	EP1286957B1 Diphenylmethane derivatives
11/03/2004	EP1267892B1 Use of cdp-choline for the treatment of alcohol withdrawal syndrome
11/03/2004	EP1261609B1 Triazolotriazinones and the use thereof
11/03/2004	EP1232153B1 Imidazole derivatives and their use as raf kinase inhibitors
11/03/2004	EP1207884B1 Use of cgrp antagonists and cgrp release inhibitors for controlling menopausal hot flashes
11/03/2004	EP1189883B1 Substituted pyrrolidines as cell adhesion inhibitors
11/03/2004	EP1121929B1 Composition comprising di- and trisodiumsalts of echinochrome for treating ocular conditions
11/03/2004	EP1094831A4 Compositions and methods for in vitro fertilization

1 ... 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 ... 1564